Amylin Pharmaceuticals (AMLN) Inactive 10-Q2003 Q2 Quarterly report

Filed: 14 Aug 03, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: afforded, aggregate, American, antibody, baseline, body, Broker, Brown, commonly, Confidential, confirm, consecutive, coupon, daily, demonstrate, Device, discontinued, drop, endpoint, entity, entry, equivalent, exceeded, extinguishment, face, failing, FASB, FIN, formation, gain, hedging, hemoglobin, highest, hybrid, hypoglycemia, Incentive, incorporated, Incorporation, Indenture, institutional, Interpretation, issuable, Julia, July, landmark, Louisiana, measure, metformin, mild, modified, National, nausea, objective, observed, percent, placebo, preliminary, primary, produced, progressed, prospectively, protocol, qualified, randomized, recommended, redemption, relationship, reliance, repaid, repay, requested, residual, Restated, rule, showed, source, statistically, submission, table, therapy, thereto, tolerated, trading, Trust, Trustee, unable, unpaid, variable

Removed: accelerated, announced, assigned, commence, committee, cook, dividend, evaluated, joseph, jr, monthly, owe, satisfactory, sensitive, significantly, testing, unamortized

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

AMLN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION

Pursuant to Section 906 of the Public Company Accounting Reform and Investor Protection Act of 2002 (18 U.S.C. § 1350, as adopted), Joseph C. Cook, Jr., the Chief Executive Officer and Chairman of the Board of Amylin Pharmaceuticals, Inc. (the “Company”), and Mark G. Foletta, the Vice President and Chief Financial Officer of the Company, each hereby certifies that, to the best of his or her knowledge:

1. The Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2003, to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”), fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Periodic Report and results of operations of the Company for the period covered by the Periodic Report.

Dated: August 13, 2003

/s/ JOSEPH C. COOK, JR.		/s/ MARK G. FOLETTA
Joseph C. Cook, Jr.		Mark G. Foletta
Chief Executive Officer and		Vice President and Chief Financial Officer
Chairman of the Board

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.